Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005056385 | SCV000774476 | likely benign | Epilepsy with myoclonic atonic seizures | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317893 | SCV000850622 | likely benign | Inborn genetic diseases | 2017-04-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001563327 | SCV001786247 | likely benign | not provided | 2020-08-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001563327 | SCV005042138 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SLC6A1: BP4, BP7 |
Prevention |
RCV004533416 | SCV004730353 | likely benign | SLC6A1-related disorder | 2021-05-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |